A Multi-Centre Clinical Study in Chronic Spinal Cord Injury Patients
1 other identifier
observational
60
2 countries
5
Brief Summary
To establish a solid foundation, e.g. network and a coordinating centre for testing new SCI therapies in forthcoming randomized controlled multi-centre clinical trials following international standards and guidelines
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Dec 2007
5 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2007
CompletedFirst Submitted
Initial submission to the registry
January 2, 2008
CompletedFirst Posted
Study publicly available on registry
January 14, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2008
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2009
CompletedJuly 3, 2009
July 1, 2009
1 year
January 2, 2008
July 2, 2009
Conditions
Outcome Measures
Primary Outcomes (1)
The primary study outcomes will be the subject recruitment rate, the subject drip out rate, the number of missing values and the number of submitted incorrect values
6 months
Eligibility Criteria
Hospital
You may qualify if:
- Male or female adult subjects, 18 to 60 years of age;
- Have a clinical diagnosis of chronic SCI (defined as a history of ≥ 12 months suffering SCI);
- The diagnosis of SCI was confirmed by MRI; and
- Voluntarily signs and dates an Informed Consent Form, approved by an Institutional Review Board (IRB)/Independent Ethics Committee (IEC), prior to any study-specific procedures
You may not qualify if:
- Severe head injury;
- Is medically or mentally unstable according to the judgement of the Investigator;
- History of Multiple Sclerosis or peripheral demyelinating disease;
- Likely to have experimental therapy;
- Any criteria, which, in the opinion of the investigator, suggests that the subject would not be compliant with the study protocol
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- China Spinal Cord Injury Networklead
- The University of Hong Kongcollaborator
Study Sites (5)
First Affiliated Hospital of Fujian Medical University
Fuzhou, Fujian, China
301 Orthopedic Hospital
Beijing, China
Second Affiliated Hospital of Third Military Medcial University
Chongqing, China
Buddhist Tzu Chi General Hospital
Hualien City, Taiwan
China Medical University Hospital
Taichung, Taiwan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Wise Young, MD, PhD
The University of Hong Kong
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- NETWORK
Study Record Dates
First Submitted
January 2, 2008
First Posted
January 14, 2008
Study Start
December 1, 2007
Primary Completion
December 1, 2008
Study Completion
March 1, 2009
Last Updated
July 3, 2009
Record last verified: 2009-07